Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/20673
Title: Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
Contributor(s): Wilkinson, Brendan  (author)orcid ; Day, Stephanie (author); Malins, Lara R (author); Apostolopoulos, Vasso (author); Payne, Richard J (author)
Publication Date: 2011
DOI: 10.1002/anie.201006115
Handle Link: https://hdl.handle.net/1959.11/20673
Abstract: The aberrant glycosylation of cell surface mucin glycoproteins such as MUC1 and the overexpression of highly truncated, tumor-associated carbohydrate antigens (TACAs) are strongly correlated with tumor metastasis and poor prognosis.[¹] Such TACAs, including the well-studied TN and T antigens and their sialylated derivatives, are important targets for the development of antigen-specific carbohydrate vaccines.[²] However, these structures are self antigens that generally elicit T-cell independent immune responses which are tolerated by the immune system and lead to poor immunogenicity.
Publication Type: Journal Article
Source of Publication: Angewandte Chemie (International Edition), 50(7), p. 1635-1639
Publisher: Wiley-VCH Verlag GmbH & Co KGaA
Place of Publication: Germany
ISSN: 1521-3773
1433-7851
Field of Research (FOR): 030406 Proteins and Peptides
030401 Biologically Active Molecules
030503 Organic Chemical Synthesis
Socio-Economic Outcome Codes: 970106 Expanding Knowledge in the Biological Sciences
970103 Expanding Knowledge in the Chemical Sciences
Peer Reviewed: Yes
HERDC Category Description: C1 Refereed Article in a Scholarly Journal
Statistics to Oct 2018: Visitors: 19
Views: 53
Downloads: 0
Appears in Collections:Journal Article

Files in This Item:
2 files
File Description SizeFormat 
Show full item record

SCOPUSTM   
Citations

83
checked on Nov 30, 2018

Page view(s)

12
checked on Feb 7, 2019
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.